OBJECTIVE: To evaluate the decline in specific neuropsychological functions in nondemented Parkinson's disease (PD) patients with a history of visual hallucinations (VH). METHODS: Twenty PD patients with VH, 20 PD patients without VH and 18 normal controls were followed up over a 1-year period and assessed for cognitive decline. RESULTS: Forty-five percent of nondemented hallucinating PD patients developed dementia during the 1-year period between baseline and follow-up evaluations. Of the nondemented hallucinating PD patients nearly 70% showed impairment in multiple cognitive domains. The progressive decline in hallucinating PD patients affected mainly visual memory for faces and visuoperceptive-visuospatial functions. CONCLUSION: Our results support a fast impairment of complex visual functions in hallucinating PD patients, but also a progressive decline in multiple cognitive domains, which have been identified as a risk of developing dementia in PD. Copyright 2007 S. Karger AG, Basel.
OBJECTIVE: To evaluate the decline in specific neuropsychological functions in nondemented Parkinson's disease (PD) patients with a history of visual hallucinations (VH). METHODS: Twenty PDpatients with VH, 20 PDpatients without VH and 18 normal controls were followed up over a 1-year period and assessed for cognitive decline. RESULTS: Forty-five percent of nondemented hallucinating PDpatients developed dementia during the 1-year period between baseline and follow-up evaluations. Of the nondemented hallucinating PDpatients nearly 70% showed impairment in multiple cognitive domains. The progressive decline in hallucinating PDpatients affected mainly visual memory for faces and visuoperceptive-visuospatial functions. CONCLUSION: Our results support a fast impairment of complex visual functions in hallucinating PDpatients, but also a progressive decline in multiple cognitive domains, which have been identified as a risk of developing dementia in PD. Copyright 2007 S. Karger AG, Basel.
Authors: Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton Journal: J Clin Exp Neuropsychol Date: 2019-06-10 Impact factor: 2.475
Authors: Jared T Hinkle; Kate Perepezko; Catherine C Bakker; Ted M Dawson; Vanessa Johnson; Zoltan Mari; Cherie L Marvel; Kelly A Mills; Alexander Pantelyat; Olga Pletnikova; Liana S Rosenthal; Melissa D Shepard; Daniel A Stevens; Juan C Troncoso; Jiangxia Wang; Gregory M Pontone Journal: Int J Geriatr Psychiatry Date: 2017-05-16 Impact factor: 3.485
Authors: G Stennis Watson; Brenna A Cholerton; Rachel G Gross; Daniel Weintraub; Cyrus P Zabetian; John Q Trojanowski; Thomas J Montine; Andrew Siderowf; James B Leverenz Journal: Alzheimers Dement Date: 2012-11-16 Impact factor: 21.566
Authors: Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson Journal: PLoS One Date: 2010-12-02 Impact factor: 3.240
Authors: Wojciech Gryc; Kathryn A Roberts; Cyrus P Zabetian; Daniel Weintraub; John Q Trojanowski; Joseph F Quinn; Amie L Hiller; Kathryn A Chung; Kathleen L Poston; Laurice Yang; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; Brenna A Cholerton Journal: J Parkinsons Dis Date: 2020 Impact factor: 5.568